Günther, R., Balck, A., Koch, J. C., Nientiedt, T., Sereda, M., Bähr, M., . . . Tönges, L. (2017). Rho Kinase Inhibition with Fasudil in the SOD1(G93A) Mouse Model of Amyotrophic Lateral Sclerosis—Symptomatic Treatment Potential after Disease Onset. Front Pharmacol.
Citación estilo ChicagoGünther, René, Alexander Balck, Jan C. Koch, Tobias Nientiedt, Michael Sereda, Mathias Bähr, Paul Lingor, y Lars Tönges. "Rho Kinase Inhibition With Fasudil in the SOD1(G93A) Mouse Model of Amyotrophic Lateral Sclerosis—Symptomatic Treatment Potential After Disease Onset." Front Pharmacol 2017.
Cita MLAGünther, René, et al. "Rho Kinase Inhibition With Fasudil in the SOD1(G93A) Mouse Model of Amyotrophic Lateral Sclerosis—Symptomatic Treatment Potential After Disease Onset." Front Pharmacol 2017.